Document Detail

Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state.
MedLine Citation:
PMID:  19898283     Owner:  NLM     Status:  MEDLINE    
The primary objective of treatment in patients with chronic coronary artery disease (CAD) and stable angina is relief of symptoms and improvement of clinical outcome. The American College of Cardiology/American Heart Association guidelines have emphasized the role of evidence-based therapies. There have been regular updates of the guidelines, with an effort to include the latest data in the recommendations. Since the 2002 guidelines were published, there have been several pivotal studies that have provided strong support for the role of aggressive and optimal medical therapy in improving clinical outcomes in patients with chronic CAD. Recent data from 2 landmark studies have emphasized that optimal medical therapy is as effective as myocardial revascularization with percutaneous coronary intervention or coronary artery bypass grafting in reducing risk of adverse clinical outcomes. The 2009-2010 guidelines will likely incorporate the findings of these studies and accordingly modify the recommendations for treatment of patients with chronic CAD and stable angina.
Prakash C Deedwania; Enrique V Carbajal
Related Documents :
20216983 - Total homocysteine in patients with angiographic coronary artery disease correlates wit...
25197023 - The relationship between gamma-glutamyl transferase levels and coronary plaque burdens ...
12888883 - Circulating t-pa antigen predicts major adverse coronary events in patients with stable...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Reviews in cardiovascular medicine     Volume:  10 Suppl 1     ISSN:  1530-6550     ISO Abbreviation:  Rev Cardiovasc Med     Publication Date:  2009  
Date Detail:
Created Date:  2009-11-09     Completed Date:  2010-11-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960007     Medline TA:  Rev Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S11-20     Citation Subset:  IM    
Cardiology Division, Department of Medicine, VA Central California Health Care System/UCSF Program, Fresno, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
American Heart Association
Angina Pectoris / diagnosis,  etiology,  therapy*
Cardiovascular Agents / therapeutic use*
Chronic Disease
Coronary Artery Disease / complications,  diagnosis,  therapy*
Drug Therapy, Combination
Evidence-Based Medicine
Myocardial Revascularization*
Practice Guidelines as Topic
Risk Assessment
Risk Factors
Treatment Outcome
United States
Reg. No./Substance:
0/Cardiovascular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ischemia is the critical determinant of revascularization benefit: an interventionalist's perspectiv...
Next Document:  Evaluating medical, percutaneous coronary intervention, and coronary artery bypass surgery options f...